Portuguese journal of public health · 2025
Antipsychotic Use during the COVID-19 Pandemic in a Portuguese Dementia Outpatient Clinic.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dias da Costa Mariana, Verdelho Ana
Аннотация
BACKGROUND: The COVID-19 pandemic and its consequent confinement have caused a major impact on people living with dementia (PLD). We aimed to ascertain the use of antipsychotic medication in this population due to behavioural symptoms during confinement.
METHODS: We conducted a retrospective study evaluating clinical registrations, namely the use of psychoactive medication, of PLD followed regularly in a Portuguese dementia outpatient clinic during two different confinement periods.
RESULTS: A total of 101 patients were included. Alzheimer's disease was the most frequent diagnosis, most of them in moderate/severe stage. Antipsychotics were used in 21.7% of patients. During confinement, a residual number of patients needed antipsychotic dose increase.
CONCLUSION: Confinement due to COVID-19 in this population was not associated with a significant increase of antipsychotics use. We hope our work may help clarify issues related to the need for antipsychotic medication in behavioural symptoms during confinement in PLD.
METHODS: We conducted a retrospective study evaluating clinical registrations, namely the use of psychoactive medication, of PLD followed regularly in a Portuguese dementia outpatient clinic during two different confinement periods.
RESULTS: A total of 101 patients were included. Alzheimer's disease was the most frequent diagnosis, most of them in moderate/severe stage. Antipsychotics were used in 21.7% of patients. During confinement, a residual number of patients needed antipsychotic dose increase.
CONCLUSION: Confinement due to COVID-19 in this population was not associated with a significant increase of antipsychotics use. We hope our work may help clarify issues related to the need for antipsychotic medication in behavioural symptoms during confinement in PLD.